Taro Pharmaceutical Industries Ltd reports results for the quarter ended in March - Earnings Summary

Taro Pharmaceutical Industries

24/05/2023 03:27

* Taro Pharmaceutical Industries Ltd  TARO.N  reported
quarterly
adjusted earnings of 18 cents​​ per share for the quarter ended
in March. The lone analyst forecast for the quarter was
for earnings of 23 cents per share.
    * Revenue rose 2.3% to $146.59 million from a year ago;
analysts
expected $150.69 million. 
    * Taro Pharmaceutical Industries Ltd's reported EPS for the
quarter was 18 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Taro Pharmaceutical Industries Ltd shares had risen
by 23.1%
this quarter and gained 3.1% so far this year.
    * The company reported quarterly net income of $6.91
million.
    * Wall Street's median 12-month price target for Taro
Pharmaceutical Industries Ltd is $35.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
24 at 02:27 a.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      0.23           0.18           Missed
 Dec. 31 2022      0.87           0.19           Missed
 Sep. 30 2022      0.84           -0.07          Missed
 Jun. 30 2022      0.85           0.37           Missed